Skip to main content
. 2011 Aug 29;174(8):919–928. doi: 10.1093/aje/kwr192

Table 3.

Hazard Ratios and 95% Confidence Intervals for Invasive Breast Cancer Incidence Associated With Smoking Status Among 76,628 Postmenopausal Women by Abdominal Obesity, the Women's Health Initiative Observational Study, United States, 1993–2009a

Exposure Nonobesity
Obesity
Pinteraction
No. of Cases Multi-adjusted HRb 95% CI No. of Cases Multi-adjusted HRb 95% CI
Smoking history
    Never smokers 1,065 1.00 Referent 603 1.00 Referent
    Ever smokers 1,092 1.16 1.07, 1.27 618 1.01 0.89, 1.13 0.02
    Smoking status 0.07
        Former smokers 963 1.16 1.05, 1.27 544 1.00 0.88, 1.13
        Current smokers 129 1.21 1.00, 1.45 74 1.06 0.83, 1.36
Age at smoking initiation, years 0.03
    <20 646 1.23 1.11, 1.37 346 0.98 0.86, 1.13
    20–24 347 1.11 0.98, 1.26 194 1.05 0.89, 1.24
    ≥25 99 0.96 0.78, 1.19 78 1.01 0.80, 1.29
            Ptrend 0.0002 0.99
Average no. of cigarettes/day 0.045
    <15 609 1.12 1.01, 1.25 311 1.02 0.89, 1.18
    ≥15 483 1.21 1.09, 1.36 307 0.99 0.86, 1.14
            Ptrend 0.0005 0.95
Total no. of smoking years 0.009
    <10 257 1.02 0.89, 1.17 127 0.98 0.81, 1.19
    10–29 505 1.18 1.05, 1.31 257 0.95 0.81, 1.10
    30–49 290 1.24 1.08, 1.41 216 1.12 0.95, 1.31
    ≥50 40 1.73 1.26, 2.39 16 0.86 0.52, 1.42
            Ptrend <0.0001 0.53
No. of smoking pack-years 0.09
    <10 462 1.07 0.95, 1.19 225 0.99 0.85, 1.16
    10–<30 382 1.29 1.14, 1.45 193 1.01 0.85, 1.19
    30–<50 141 1.15 0.97, 1.38 93 0.93 0.75, 1.17
    ≥50 107 1.22 0.99, 1.49 107 1.12 0.91, 1.38
            Ptrend 0.0004 0.59
Years since quit smoking (former smokers) 0.5
    <10 156 1.23 1.04, 1.46 122 0.94 0.73, 1.20
    10–<20 238 1.18 1.04, 1.39 154 1.02 0.82, 1.26
    20–<30 242 1.11 0.97, 1.28 119 0.94 0.74, 1.19
    ≥30 263 1.13 0.98, 1.29 126 0.95 0.75, 1.20
            Ptrend 0.002 0.78

Abbreviations: CI, confidence interval; HR, hazard ratio.

a

“Abdominal obesity” was defined by waist circumference ≥88 cm.

b

The adjusted variables in all multi-adjusted models included age (<55, 55–59, 60–64, 65–69, 70–74, ≥75), race (American Indian or Alaska Native, Asian or Pacific Islander, black or African American, Hispanic/Latino, non-Hispanic white, and other), education (high school or less, some college/technical training, college or some postcollege, and master's degree or higher), family history of cancer (yes/no), age at menarche (<12, 12–13, 14–15, ≥16 years), age at first livebirth (never had term pregnancy, <20, 20–29, ≥30 years), hormone use (no, estrogen alone, estrogen and progestin, mixed), parity (never pregnant, never had term pregnancy, 1, 2, 3, 4, ≥5), alcohol intake (nondrinker, past drinker, <1 drink/month, 1 drink/month–<1 drink/week, 1–<7 drinks/week, ≥7 drinks/week), body mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9, 35.0–39.9, ≥40), physical activity (metabolic equivalent tasks/week: <5, 5–<10, 10–<20, 20–<30, ≥30), and mammography during the last 2 years (yes/no). The Ptrend test included the reference group.